Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’

por Khani, Elnaz, Entezari-Maleki, Taher
Publicado 2023

Enoxaparin’s potential mechanisms against SARS-CoV-2

por Afsharirad, Bentelhoda, Entezari-Maleki, Taher
Publicado 2023

Anticoagulation in COVID-19: DDI Perspective

por Khiali, Sajad, Entezari-Maleki, Taher
Publicado 2020

Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists

por Khani, Elnaz, Entezari-Maleki, Taher
Publicado 2022

A commentary on “Unexpected sudden rise of human monkeypox cases in multiple non-endemic countries amid COVID-19 pandemic and salient counteracting strategies: Another potential gl...

por Khani, Elnaz, Entezari-Maleki, Taher
Publicado 2022

Tocilizumab in COVID-19 management: addressing time of starting treatment

por Khiali, Sajad, Entezari-Maleki, Taher
Publicado 2023

Isotretinoin; A review on the Utilization Pattern in Pregnancy

por Khiali, Sajad, Gharekhani, Afshin, Entezari-Maleki, Taher
Publicado 2018

SARS-CoV-2 and probable lung cancer risk

por Khiali, Sajad, Rezagholizadeh, Afra, Entezari-Maleki, Taher
Publicado 2022

Approach to Anemia in Hospitalized Patients with Infectious Diseases; Is it Appropriate?

por Entezari-Maleki, Taher, Khalili, Hossein, Karimzadeh, Iman, Jafari, Sirous
Publicado 2015

A review of Vitamin D effects on common respiratory diseases: Asthma, chronic obstructive pulmonary disease, and tuberculosis

por Hejazi, Mohammad Esmaeil, Modarresi-Ghazani, Faezeh, Entezari-Maleki, Taher
Publicado 2016

Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis

por Rezagholizadeh, Afra, Khiali, Sajad, Sarbakhsh, Parvin, Entezari-Maleki, Taher
Publicado 2021

Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review

por Khani, Elnaz, Khiali, Sajad, Beheshtirouy, Samineh, Entezari-Maleki, Taher
Publicado 2021

Vitamin D Deficiency Predicts the ST Elevation Type of Myocardial Infarction in Patients with Acute Coronary Syndrome

por Safaie, Naser, Rezaee, Haleh, Seif Dvati, Babak, Entezari-Maleki, Taher
Publicado 2018

Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic

por Khiali, Sajad, Khani, Elnaz, B Rouy, Samineh, Entezari-Maleki, Taher
Publicado 2022

Evaluation of Clinical Pharmacy Services in the Intensive Care Unit of a Tertiary University Hospital in the Northwest of Iran

por Mahmoodpoor, Ata, Kalami, Arman, Shadvar, Kamran, Entezari-Maleki, Taher, Hamishehkar, Hadi
Publicado 2018

The Streptokinase Therapy Complications and its Associated Risk Factors in Patients with Acute ST Elevation Myocardial Infarction

por Aslanabadi, Naser, Safaie, Naser, Talebi, Fereshteh, Dousti, Samaneh, Entezari-Maleki, Taher
Publicado 2018

SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis

por Aghbash, Parisa Shiri, Eslami, Narges, Shamekh, Ali, Entezari-Maleki, Taher, Baghi, Hossein Bannazadeh
Publicado 2021

SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs

por Rasizadeh, Reyhaneh, Aghbash, Parisa Shiri, Nahand, Javid Sadri, Entezari-Maleki, Taher, Baghi, Hossein Bannazadeh
Publicado 2023

Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview

por Rezaee, Haleh, Pourkarim, Fariba, Pourtaghi‐Anvarian, Samira, Entezari‐Maleki, Taher, Asvadi‐Kermani, Touraj, Nouri‐Vaskeh, Masoud
Publicado 2021

Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary inter...

por Khiali, Sajad, Taban-Sadeghi, Mohammadreza, Sarbakhsh, Parvin, Khezerlouy-Aghdam, Naser, Namdar, Hossein, Salehi, Rezvanieh, Rezagholizadeh, Afra, Entezari-Maleki, Taher
Publicado 2023